Patent · US Active

Methods and compositions for the prevention and treatment of hearing loss

US12427149B2 · kind B2 · utility

0Cited by
24References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2022
Grant dateSep 30, 2025
Priority date—
Expiry dateJan 10, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Method, kit and pharmaceutical compositions using an inhibitor of EGFR signaling for prevention or treatment of hearing loss are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.